# Foghorn Therapeutics Inc.: Form 8-K, filed Jan 10, 2022

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2022-01-10
- Accepted by EDGAR: Jan 10, 2022, 12:03 ET
- Period: 2022-01-10
- Accession: 0001628280-22-000561
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828022000561/fhtx-20220110.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828022000561/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828022000561/fhtx-20220110.htm

Filed Jan 10, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-000561. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
